MARK2 and lung cancer: To delineate the role of the Akt1 and Akt2 serine/threonine kinases in lung cancer progression, we first used the Akt1 and Akt2 small interfering RNA (siRNA) duplex targeting the human Akt1 and Akt2 transcript respectively22.